tert-Butyl 3-(1-amino-2-methylpropan-2-yl)-1H-indole-1-carboxylate

Catalog No.: 
ACABIC235
CAS No.: 
942148-12-1
Molecular Formula: 
C17H24N2O2
Molecular Weight: 
288.39
tert-Butyl 3-(1-amino-2-methylpropan-2-yl)-1H-indole-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$53.00InquiryInquiry
1g95%$173.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(1-amino-2-methylpropan-2-yl)-1H-indole-1-carboxylate
IUPAC Nametert-butyl 3-(1-amino-2-methylpropan-2-yl)-1H-indole-1-carboxylate
MDL No.MFCD18642771
Molecular FormulaC17H24N2O2
Molecular Weight288.39
SMILESO=C(N1C=C(C(C)(C)CN)C2=C1C=CC=C2)OC(C)(C)C
InChI KeyQKNNTRWRJFJHCT-UHFFFAOYSA-N
SynonymTERT-BUTYL 3-(1-AMINO-2-METHYLPROPAN-2-YL)-1H-INDOLE-1-CARBOXYLATE;3-(2-amino-1,1-dimethylethyl)-indole-1-carboxylic acid tert-butyl ester;1H-Indole-1-carboxylic acid, 3-(2-amino-1,1-dimethylethyl)-, 1,1-dimethylethyl ester
CAS No.942148-12-1
PubChem CID57817593

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACABIC235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACABIC235 route product structure diagram
    ACABIC235942148-12-1
Inquiry

2. ACABIC235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACABIC235 route product structure diagram
    ACABIC235942148-12-1
Inquiry

3. ACABIC235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACABIC235 route product structure diagram
    ACABIC235942148-12-1
Inquiry

Comments (0)